Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2024/12/077754
CTRI/2024/12/077754Not yet recruitingPhase 2/3

A clinical study of the effect of Simhasyadi kwatha in the management of Hyperuricemia.

Dr Aditi Acharya1 site in 1 country60 target enrollmentStarted: December 17, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a clinical study of SIMHASYADI KWATHA in management of Hyperuricemia. This study is done as a mandatory Post graduation thesis work. Total number of 60 patients will be studied for 60 days each.

Study Design

Study Type
Interventional
Allocation
Other
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Patients of both the sex and age between 20-70 years.2.Naive patients or newly diagnosed patients of Hyperuricemia.3.Patients having serum uric acid more than 6.9mg/dl.
  • •Patients of Hyperuricemia with Gouty Arthritis.5.Patient recently diagnosed with uncomplicated Hyperuricemia & Gouty Arthritis.6.Hyperuricemic patients suffering from controlled hypertension, diabetes mellitus, CKD upto stage 3.

Exclusion Criteria

  • •1.Asymptomatic patient with Hyperuricemia.
  • •2.Patients suffering from the complications of Hyperuricemia & Gouty Arthritis.
  • •3.Pregnant and lactating women.
  • •4.Presence of disease like CA, HIV, malignant hypertension, uncontrolled diabetes.
  • •Patients suffering from major systemic illness or under long term drug treatment.

Outcomes

Primary Outcomes

To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.

Time Frame: 45 days

Secondary Outcomes

  • To compare the effect of SIMHASYADI KWATHA and FEBUXOSTAT on serum uric acid level parameter.(30, 45 and 60 days)

Investigators

Sponsor
Dr Aditi Acharya
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Aditi Acharya

Govt Ayurvedic College and Hospital Guwahati

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
A Clinical Study on the management of Acne Vulgaris
CTRI/2025/07/090490Dr Chevikula Sai Deepika30
Recruiting
Phase 3
To see the action of Shunthyadi kwath and Gokshuradi guggulu in renal stone
CTRI/2025/09/094892Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan30
Not yet recruiting
Phase 3
Study on the Role of Amritadi Kwath and Trivrittadi Kwath in the Management of Gout (Vatarakta)
CTRI/2025/10/096304self sponsered120
Not yet recruiting
Phase 2
Study on patients with Allergic Rhinitis(Vataja Pratishyaya) to evaluate the effect of two herbal decoctions (Shirishadi Kwath and Gojihwadi Kwath) given orally along with Ayurvedic nasal drops (Vidaryadi Ghrita Nasya)
CTRI/2025/09/094335Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar60
Not yet recruiting
Phase 2/3
To Study The Effect Of kutaj Ghrita In The Management Of Dushta Vrana With Special Reference To Infected Wound
CTRI/2025/10/095780Dr Shamal Balkrishna Shirale226